<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Rivastigmine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Rivastigmine">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Rivastigmine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Rivastigmine</b> (sold under the trade name <b>Exelon</b> among others) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's.<span class="mw-ref" id="cite_ref-Khoury_Rajamanickam_Grossberg_2018_pp._171–178_1-0"><a href="#cite_note-Khoury_Rajamanickam_Grossberg_2018_pp._171–178-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects,<span class="mw-ref" id="cite_ref-Winblad_2-0"><a href="#cite_note-Winblad-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> which typically include nausea and vomiting.<span class="mw-ref" id="cite_ref-Inglis_3-0"><a href="#cite_note-Inglis-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Rivastigmine</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Rivastigmine_Structural_Formulae.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rivastigmine_Structural_Formulae.png" data-file-width="2797" data-file-height="922" data-file-type="bitmap" height="73" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Rivastigmine_ball-and-stick.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rivastigmine_ball-and-stick.png" data-file-width="2000" data-file-height="1418" data-file-type="bitmap" height="156" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Exelon, Prometax, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/rivastigmine.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/rivastigmine.html'" tppabs="https://www.drugs.com/monograph/rivastigmine.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a602009.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a602009.html'" tppabs="https://medlineplus.gov/druginfo/meds/a602009.html" class="external text external">a602009</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Rivastigmine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Rivastigmine'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Rivastigmine" class="external text external">by INN</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>B (No risk in non-human studies)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Oral &amp; transdermal patch</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N06DA03<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N06DA03  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N06DA03'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N06DA03" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>60 to 72%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>40%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver, via pseudocholinesterase</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>1.5 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>97% in urine</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>S</i>)-3-[1-(dimethylamino)ethyl]phenyl <i>N</i>-ethyl-<i>N</i>-methylcarbamate</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=123441-03-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=123441-03-2'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=123441-03-2" class="external text external">123441-03-2</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/77991  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/77991'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/77991" class="external text external">77991</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6602  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6602'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6602" class="external text external">6602</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00989  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00989'" tppabs="https://www.drugbank.ca/drugs/DB00989" class="external text external">DB00989</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.70377.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.70377.html'" tppabs="http://www.chemspider.com/Chemical-Structure.70377.html" class="external text external">70377</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PKI06M3IW0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PKI06M3IW0'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=PKI06M3IW0" class="external text external">PKI06M3IW0</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D03822  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D03822'" tppabs="https://www.kegg.jp/entry/D03822" class="external text external">D03822</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8874  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8874'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8874" class="external text external">CHEBI:8874</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL636'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL636" class="external text external">ChEMBL636</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID7023564  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID7023564'" tppabs="https://comptox.epa.gov/dashboard/DTXSID7023564" class="external text external">DTXSID7023564</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.120.679  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.120.679'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.120.679" class="external text external">100.120.679</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>14</sub><span>H</span><sub>22</sub><span>N</span><sub>2</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">250.342</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28Oc1cc%28ccc1%29%5BC%40%40H%5D%28N%28C%29C%29C%29N%28CC%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28Oc1cc%28ccc1%29%5BC%40%40H%5D%28N%28C%29C%29C%29N%28CC%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28Oc1cc%28ccc1%29%5BC%40%40H%5D%28N%28C%29C%29C%29N%28CC%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(Oc1cc(ccc1)[C@@H](N(C)C)C)N(CC)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:XSVMFMHYUFZWBK-NSHDSACASA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464382904&page2=Rivastigmine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464382904&page2=Rivastigmine'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464382904&page2=Rivastigmine" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.<span class="mw-ref" id="cite_ref-Inglis_3-1"><a href="#cite_note-Inglis-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


<p>It was patented in 1985 and came into medical use in 1997.<span class="mw-ref" id="cite_ref-Fis2006_4-0"><a href="#cite_note-Fis2006-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Rivastigmine capsules, liquid solution and patches are used for the treatment of mild to moderate dementia of the Alzheimer's type and for mild to moderate dementia related to Parkinson's disease.</p>

<p>Rivastigmine has demonstrated treatment effects on the cognitive (thinking and memory), functional (activities of daily living) and behavioural problems commonly associated with Alzheimer's<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> and Parkinson's disease dementias.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Efficacy">Efficacy</h3></summary>
    
<p>In people with either type of dementia, rivastigmine has been shown to provide meaningful symptomatic effects that may allow patients to remain independent and ‘be themselves’ for longer. In particular, it appears to show marked treatment effects in patients showing a more aggressive course of disease, such as those with younger onset ages, poor nutritional status, or those experiencing symptoms such as delusions or hallucinations.<span class="mw-ref" id="cite_ref-ReferenceA_10-0"><a href="#cite_note-ReferenceA-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span>  For example, the presence of hallucinations appears to be a predictor of especially strong responses to rivastigmine, both in Alzheimer's and Parkinson's  patients.<span class="mw-ref" id="cite_ref-ReferenceB_11-0"><a href="#cite_note-ReferenceB-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> These effects might reflect the additional inhibition of butyrylcholinesterase, which is implicated in symptom progression and might provide added benefits over acetylcholinesterase-selective drugs in some patients.<span class="mw-ref" id="cite_ref-ReferenceA_10-1"><a href="#cite_note-ReferenceA-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-ReferenceB_11-1"><a href="#cite_note-ReferenceB-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Multiple-infarct dementia patients may show slight improvement in executive functions and behaviour. No firm evidence supports usage in schizophrenia patients.</p>

<p>Its efficacy is similar to <a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">donepezil</a> and <a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">tacrine</a>. Doses below 6<span>&nbsp;</span>mg/d may be ineffective. The effects of this kind of drug in different kinds of dementia (including Alzheimer's dementia) are modest, and it is still unclear which AChE (BChE) esterase inhibitor is better in Parkinson's dementia, though rivastigmine is well-studied.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Side effects may include nausea and vomiting, decreased appetite and weight loss.<span class="mw-ref" id="cite_ref-Inglis_3-2"><a href="#cite_note-Inglis-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>The strong potency of rivastigmine, provided by its dual inhibitory mechanism, has been postulated to lead to more nausea and vomiting during the titration phase of oral rivastigmine treatment.<span class="mw-ref" id="cite_ref-Inglis_3-3"><a href="#cite_note-Inglis-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> This enforces the importance of taking oral forms of these drugs with food as prescribed.<span class="mw-ref" id="cite_ref-ProductInsert_13-0"><a href="#cite_note-ProductInsert-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span>   However, rates of nausea and vomiting are markedly reduced with the once-daily rivastigmine patch (which can be applied at any time of the day, with or without food).
Patients and caregivers should be aware of warning signs of potential toxicities and know when to call their doctor. For the patch and oral formulations, skin rashes can occur at which time patients should contact their doctor immediately.<span class="mw-ref" id="cite_ref-pharma.us.novartis.com_14-0"><a href="#cite_note-pharma.us.novartis.com-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> For the patch, patients and caregivers should monitor for any intense itching, redness, swelling or blistering at the patch location. If this occurs, remove the patch, rinse the area and call the doctor immediately.<span class="mw-ref" id="cite_ref-exelonpatch.com_15-0"><a href="#cite_note-exelonpatch.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>In a large clinical trial of the rivastigmine patch in 1,195 patients with Alzheimer's disease, the target dose of 9.5<span>&nbsp;</span>mg/24-hour patch provided similar clinical effects (e.g. memory and thinking, activities of daily living, concentration) as the highest doses of rivastigmine capsules, but with one-third fewer reports of nausea and vomiting.<span class="mw-ref" id="cite_ref-Winblad_2-1"><a href="#cite_note-Winblad-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Usage of rivastigmine was associated with a higher frequency of reports of death as an adverse event in the Food and Drug Administration Adverse Event Reporting System database compared to the other acetylcholinesterase inhibiting drugs donepezil and galantamine.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Administration">Administration</h2></summary>
    
<p>Rivastigmine tartrate is a white to off-white, fine crystalline powder that is both lipophilic (soluble in fats) and hydrophilic (soluble in water). It comes in a variety of administrations including a capsule, solution and a transdermal patch. Like other cholinesterase inhibitors, it requires doses to be increased gradually over several weeks; this is usually referred to as the titration phase.<span class="mw-ref" id="cite_ref-Inglis_3-4"><a href="#cite_note-Inglis-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Oral doses of rivastigmine should be titrated with a 3<span>&nbsp;</span>mg per day increment every 2 to 4 weeks.
For oral dosing, an initial dose of 1.5<span>&nbsp;</span>mg twice daily is recommended followed by an increase by 1.5<span>&nbsp;</span>mg/dose after four weeks. The dose should increase as long as side effects are tolerable. Patients should be reminded to take with food. For the transdermal patch, an initial dose of 4.6<span>&nbsp;</span>mg per day increases to 9.5<span>&nbsp;</span>mg per day after four weeks if the patient is not experiencing any intolerable side effects.<span class="mw-ref" id="cite_ref-pharma.us.novartis.com_14-1"><a href="#cite_note-pharma.us.novartis.com-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Patients or caregivers should be reminded to remove the old patch every day, rotate sites and place a new one. It is recommended that the patch be applied to the upper back or torso.<span class="mw-ref" id="cite_ref-exelonpatch.com_15-1"><a href="#cite_note-exelonpatch.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Rivastigmine is classified as pregnancy category B, with insufficient data on risks associated with breastfeeding. In cases of overdose, <a href="Atropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atropine" title="Atropine">atropine</a> is used to reverse bradycardia.  Dialysis is ineffective due to the drug's half-life.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacodynamics">Pharmacodynamics</h2></summary>
    
<p>Rivastigmine, a cholinesterase inhibitor, inhibits both butyrylcholinesterase and acetylcholinesterase (unlike <a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">donepezil</a>, which selectively inhibits acetylcholinesterase). It is thought to work by inhibiting these cholinesterase enzymes, which would otherwise break down the brain neurotransmitter acetylcholine.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    

<p>When given orally, rivastigmine is well absorbed, with a bioavailability of about 40% in the 3-mg dose.  Pharmacokinetics are linear up to 3<span>&nbsp;</span>mg BID, but nonlinear at higher doses.  Elimination is through the urine.  Peak plasma concentrations are seen in about one hour, with peak cerebrospinal fluid concentrations at 1.4–3.8 hours.   When given by once-daily transdermal patch, the pharmacokinetic profile of rivastigmine is much smoother, compared with capsules, with lower peak plasma concentrations and reduced fluctuations.<span class="mw-ref" id="cite_ref-Cummings_18-0"><a href="#cite_note-Cummings-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> The 9.5<span>&nbsp;</span>mg/24 h rivastigmine patch provides comparable exposure to 12<span>&nbsp;</span>mg/day capsules (the highest recommended oral dose).<span class="mw-ref" id="cite_ref-Cummings_18-1"><a href="#cite_note-Cummings-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>The compound does cross the blood–brain barrier. Plasma protein binding is 40%.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> The major route of metabolism is by its target enzymes via cholinesterase-mediated hydrolysis.  Elimination bypasses the hepatic system, so hepatic cytochrome P450 (CYP) isoenzymes are not involved.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> The low potential for drug-drug interactions (which could lead to adverse effects) has been suggested as due to this pathway compared to the many common drugs that use the cytochrome P450 metabolic pathway.<span class="mw-ref" id="cite_ref-Inglis_3-5"><a href="#cite_note-Inglis-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Rivastigmine was developed by Marta Weinstock-Rosin of the Department of Pharmacology at the Hebrew University of Jerusalem<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> and sold to Novartis by Yissum for commercial development. It is a semi-synthetic derivative of <a href="Physostigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Physostigmine" title="Physostigmine">physostigmine</a>.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span>  It has been available in capsule and liquid formulations since 1997.<span class="mw-ref" id="cite_ref-ProductInsert_13-1"><a href="#cite_note-ProductInsert-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> In 2006, it became the first product approved globally for the treatment of mild to moderate dementia associated with Parkinson's disease;<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> and in 2007 the rivastigmine transdermal patch became the first patch treatment for dementia.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Dimebon</li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Khoury_Rajamanickam_Grossberg_2018_pp._171–178-1"> <span id="mw-reference-text-cite_note-Khoury_Rajamanickam_Grossberg_2018_pp._171–178-1" class="mw-reference-text"><cite id="CITEREFKhouryRajamanickamGrossberg2018" class="citation journal cs1">Khoury, Rita; Rajamanickam, Jayashree; Grossberg, George T. (2018-01-08). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810854  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810854'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810854" class="external text external">"An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine"</a>. <i>Therapeutic Advances in Drug Safety</i>. SAGE Publications. <b>9</b> (3): 171–178. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F2042098617750555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F2042098617750555'" tppabs="https://doi.org/10.1177%2F2042098617750555" class="external text external">10.1177/2042098617750555</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/2042-0986  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/2042-0986'" tppabs="https://www.worldcat.org/issn/2042-0986" class="external text external">2042-0986</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810854  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810854'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810854" class="external text external">5810854</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29492246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29492246'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29492246" class="external text external">29492246</a>.</cite></span></li><li id="cite_note-Winblad-2"> <span id="mw-reference-text-cite_note-Winblad-2" class="mw-reference-text"><cite id="CITEREFWinbladGrossbergFrölichFarlow2007" class="citation journal cs1">Winblad, B.; Grossberg, G.; Frölich, L.; Farlow, M.; Zechner, S.; Nagel, J.; Lane, R. (2007). "IDEAL: A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease". <i>Neurology</i>. <b>69</b> (4 Suppl 1): S14–S22. doi:<a href="javascript:if(confirm('https://doi.org/10.1212%2F01.wnl.0000281847.17519.e0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2F01.wnl.0000281847.17519.e0'" tppabs="https://doi.org/10.1212%2F01.wnl.0000281847.17519.e0" class="external text external">10.1212/01.wnl.0000281847.17519.e0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17646619  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17646619'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17646619" class="external text external">17646619</a>.</cite></span></li><li id="cite_note-Inglis-3"> <span id="mw-reference-text-cite_note-Inglis-3" class="mw-reference-text"><cite id="CITEREFInglis2002" class="citation journal cs1">Inglis, F. (2002). "The tolerability and safety of cholinesterase inhibitors in the treatment of dementia". <i>International Journal of Clinical Practice. Supplement</i> (127): 45–63. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12139367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12139367'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12139367" class="external text external">12139367</a>.</cite></span></li><li id="cite_note-Fis2006-4"> <span id="mw-reference-text-cite_note-Fis2006-4" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Jnos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA540  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA540'" tppabs="https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA540" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>540. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFCorey-BloomAnandVeach1998" class="citation journal cs1">Corey-Bloom, J.; Anand, R.; Veach, J. (1998). <a href="javascript:if(confirm('https://www.researchgate.net/publication/284814323  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.researchgate.net/publication/284814323'" tppabs="https://www.researchgate.net/publication/284814323" class="external text external">"A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease"</a>. <i>International Journal of Geriatric Psychopharmacology</i>. <b>1</b> (2): 55–65.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFRoslerAnandCicin-SainGauthier1999" class="citation journal cs1">Rosler, M.; Anand, R.; Cicin-Sain, A.; Gauthier, S.; Agid, Y.; Dal-Bianco, P.; Stähelin, H. B.; Hartman, R.; Gharabawi, M.; Bayer, T. (1999). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27767  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27767'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27767" class="external text external">"Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial Commentary: Another piece of the Alzheimer's jigsaw"</a>. <i>BMJ</i>. <b>318</b> (7184): 633–638. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.318.7184.633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.318.7184.633'" tppabs="https://doi.org/10.1136%2Fbmj.318.7184.633" class="external text external">10.1136/bmj.318.7184.633</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27767  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27767'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC27767" class="external text external">27767</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10066203  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10066203'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10066203" class="external text external">10066203</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFFinkel2004" class="citation journal cs1">Finkel, S. I. (2004). "Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease". <i>Clinical Therapeutics</i>. <b>26</b> (7): 980–990. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0149-2918%2804%2990172-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0149-2918%2804%2990172-5'" tppabs="https://doi.org/10.1016%2FS0149-2918%2804%2990172-5" class="external text external">10.1016/S0149-2918(04)90172-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15336465  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15336465'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15336465" class="external text external">15336465</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFRöslerRetzRetz-JungingerDennler1998" class="citation journal cs1">Rösler, M.; Retz, W.; Retz-Junginger, P.; Dennler, H. J. (1998). <a href="javascript:if(confirm('https://doi.org/10.1155/1999/168023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1155/1999/168023'" tppabs="https://doi.org/10.1155/1999/168023" class="external text external">"Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer's disease"</a>. <i>Behavioural Neurology</i>. <b>11</b> (4): 211–216. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1155%2F1999%2F168023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1155%2F1999%2F168023'" tppabs="https://doi.org/10.1155%2F1999%2F168023" class="external text external">10.1155/1999/168023</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11568422  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11568422'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11568422" class="external text external">11568422</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFEmreAarslandAlbaneseByrne2004" class="citation journal cs1">Emre, M.; Aarsland, D.; Albanese, A.; Byrne, E. J.; Deuschl, G. N.; De Deyn, P. P.; Durif, F.; Kulisevsky, J.; Van Laar, T.; Lees, A.; Poewe, W.; Robillard, A.; Rosa, M. M.; Wolters, E.; Quarg, P.; Tekin, S.; Lane, R. (2004). <a href="javascript:if(confirm('http://discovery.ucl.ac.uk/7612/1/7612.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://discovery.ucl.ac.uk/7612/1/7612.pdf'" tppabs="http://discovery.ucl.ac.uk/7612/1/7612.pdf" class="external text external">"Rivastigmine for Dementia Associated with Parkinson's Disease"</a> <span class="cs1-format">(PDF)</span>. <i>New England Journal of Medicine</i>. <b>351</b> (24): 2509–2518. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa041470  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa041470'" tppabs="https://doi.org/10.1056%2FNEJMoa041470" class="external text external">10.1056/NEJMoa041470</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15590953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15590953'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15590953" class="external text external">15590953</a>.</cite></span></li><li id="cite_note-ReferenceA-10"> <span id="mw-reference-text-cite_note-ReferenceA-10" class="mw-reference-text"><cite id="CITEREFGauthierVellasFarlowBurn2006" class="citation journal cs1">Gauthier, S.; Vellas, B.; Farlow, M.; Burn, D. (2006). "Aggressive course of disease in dementia". <i>Alzheimer's &amp; Dementia</i>. <b>2</b> (3): 210–217. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jalz.2006.03.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jalz.2006.03.002'" tppabs="https://doi.org/10.1016%2Fj.jalz.2006.03.002" class="external text external">10.1016/j.jalz.2006.03.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19595889  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19595889'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19595889" class="external text external">19595889</a>.</cite></span></li><li id="cite_note-ReferenceB-11"> <span id="mw-reference-text-cite_note-ReferenceB-11" class="mw-reference-text"><cite id="CITEREFTouchonBergmanBullockRapatz2006" class="citation journal cs1">Touchon, J.; Bergman, H.; Bullock, R.; Rapatz, G. N.; Nagel, J.; Lane, R. (2006). "Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology". <i>Current Medical Research and Opinion</i>. <b>22</b> (1): 49–59. doi:<a href="javascript:if(confirm('https://doi.org/10.1185%2F030079906X80279  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1185%2F030079906X80279'" tppabs="https://doi.org/10.1185%2F030079906X80279" class="external text external">10.1185/030079906X80279</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16393430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16393430'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16393430" class="external text external">16393430</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFBurnEmreMcKeithDe_Deyn2006" class="citation journal cs1">Burn, D.; Emre, M.; McKeith, I.; De Deyn, P. P.; Aarsland, D.; Hsu, C.; Lane, R. (2006). "Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease". <i>Movement Disorders</i>. <b>21</b> (11): 1899–1907. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fmds.21077  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fmds.21077'" tppabs="https://doi.org/10.1002%2Fmds.21077" class="external text external">10.1002/mds.21077</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16960863  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16960863'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16960863" class="external text external">16960863</a>.</cite></span></li><li id="cite_note-ProductInsert-13"> <span id="mw-reference-text-cite_note-ProductInsert-13" class="mw-reference-text"><a href="javascript:if(confirm('http://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf'" tppabs="http://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf" class="external text external">Novartis Pharmaceuticals Corporation "Exelon Product Insert" June 2006</a></span></li><li id="cite_note-pharma.us.novartis.com-14"> <span id="mw-reference-text-cite_note-pharma.us.novartis.com-14" class="mw-reference-text"><a href="javascript:if(confirm('https://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf%5B%5D  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf%5B%5D'" tppabs="https://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf%5B%5D" class="external free external">https://www.pharma.us.novartis.com/product/pi/pdf/exelon.pdf%5B%5D</a></span></li><li id="cite_note-exelonpatch.com-15"> <span id="mw-reference-text-cite_note-exelonpatch.com-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.exelonpatch.com/info/alzheimers-dementia-help/applying-exelon-patch.jsp?usertrack.filter_applied=true&NovaId=2935376991487123443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.exelonpatch.com/info/alzheimers-dementia-help/applying-exelon-patch.jsp?usertrack.filter_applied=true&NovaId=2935376991487123443'" tppabs="http://www.exelonpatch.com/info/alzheimers-dementia-help/applying-exelon-patch.jsp?usertrack.filter_applied=true&NovaId=2935376991487123443" class="external text external">"Treat Alzheimer's <span>|</span> Exelon® Patch (Rivastigmine transdermal system)"</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFAliSchleretReillyChen2015" class="citation journal cs1">Ali TB, Schleret TR, Reilly BM, Chen WY, Abagyan R (2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671709  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671709'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671709" class="external text external">"Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada"</a>. <i>PLOS ONE</i>. <b>10</b> (12): e0144337. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2015PLoSO..1044337A  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2015PLoSO..1044337A'" tppabs="https://ui.adsabs.harvard.edu/abs/2015PLoSO..1044337A" class="external text external">2015PLoSO..1044337A</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0144337  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0144337'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0144337" class="external text external">10.1371/journal.pone.0144337</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671709  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671709'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671709" class="external text external">4671709</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26642212  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26642212'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26642212" class="external text external">26642212</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFCamps2002" class="citation journal cs1">Camps, P. Munoz-Torrero D. (Feb 2002). "Cholinergic drugs in pharmacotherapy of Alzheimer's disease". <i>Mini Rev Med Chem</i>. <b>2</b> (1): 11–25. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F1389557023406638  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F1389557023406638'" tppabs="https://doi.org/10.2174%2F1389557023406638" class="external text external">10.2174/1389557023406638</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12369954  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12369954'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12369954" class="external text external">12369954</a>.</cite></span></li><li id="cite_note-Cummings-18"> <span id="mw-reference-text-cite_note-Cummings-18" class="mw-reference-text"><cite id="CITEREFCummingsLefevreSmallAppel-Dingemanse2007" class="citation journal cs1">Cummings, J.; Lefevre, G.; Small, G.; Appel-Dingemanse, S. (2007). "Pharmacokinetic rationale for the rivastigmine patch". <i>Neurology</i>. <b>69</b> (4 Suppl 1): S10–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1212%2F01.wnl.0000281846.40390.50  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2F01.wnl.0000281846.40390.50'" tppabs="https://doi.org/10.1212%2F01.wnl.0000281846.40390.50" class="external text external">10.1212/01.wnl.0000281846.40390.50</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17646618  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17646618'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17646618" class="external text external">17646618</a>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFJannShirleySmall2002" class="citation journal cs1">Jann, M. W.; Shirley, K. L.; Small, G. W. (2002). "Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors". <i>Clinical Pharmacokinetics</i>. <b>41</b> (10): 719–739. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200241100-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200241100-00003'" tppabs="https://doi.org/10.2165%2F00003088-200241100-00003" class="external text external">10.2165/00003088-200241100-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12162759  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12162759'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12162759" class="external text external">12162759</a>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFJann2000" class="citation journal cs1">Jann, M. W. (2000). "Rivastigmine, a New-Generation Cholinesterase Inhibitor for the Treatment of Alzheimer's Disease". <i>Pharmacotherapy</i>. <b>20</b> (1): 1–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.20.1.1.34664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.20.1.1.34664'" tppabs="https://doi.org/10.1592%2Fphco.20.1.1.34664" class="external text external">10.1592/phco.20.1.1.34664</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10641971  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10641971'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10641971" class="external text external">10641971</a>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.yissum.co.il/success.php?cat=12&in=0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.yissum.co.il/success.php?cat=12&in=0'" tppabs="http://www.yissum.co.il/success.php?cat=12&in=0" class="external text external">"Exelon"</a>. Yissum Technology Transfer<span class="reference-accessdate">. Retrieved <span class="nowrap">7 October</span> 2010</span>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFKumar2006" class="citation journal cs1">Kumar, V. (2006). "Potential medicinal plants for CNS disorders: An overview". <i>Phytotherapy Research</i>. <b>20</b> (12): 1023–1035. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fptr.1970  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fptr.1970'" tppabs="https://doi.org/10.1002%2Fptr.1970" class="external text external">10.1002/ptr.1970</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16909441  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16909441'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16909441" class="external text external">16909441</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><a href="javascript:if(confirm('https://www.fda.gov/bbs/topics/NEWS/2006/NEW01399.htmlFDA  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/bbs/topics/NEWS/2006/NEW01399.htmlFDA'" tppabs="https://www.fda.gov/bbs/topics/NEWS/2006/NEW01399.htmlFDA" class="external text external">Approves the First Treatment for Dementia of Parkinson's Disease U.S. FDA News Release</a></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><i>Proteopedia <a href="javascript:if(confirm('http://www.proteopedia.org/wiki/index.php/1gqr  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.proteopedia.org/wiki/index.php/1gqr'" tppabs="http://www.proteopedia.org/wiki/index.php/1gqr" class="external text external">1gqr</a></i></li>
<li><a href="javascript:if(confirm('http://www.yissum.co.il/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.yissum.co.il/'" tppabs="http://www.yissum.co.il/" class="external text external">Yissum</a> – Owners of the original patent for Rivastigmine.</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Psychoanaleptics:_Anti-dementia_agents_(ATC_code_N06D_and_others)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Psychoanaleptics:_Anti-dementia_agents_(ATC_code_N06D_and_others)" style="font-size:114%;margin:0 4em">Psychoanaleptics: Anti-dementia agents (ATC code N06D and others)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">AChE inhibitor medications</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">Donepezil</a></li>
<li><a href="Galantamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Galantamine" title="Galantamine">Galantamine</a></li>
<li>Ipidacrine</li>
<li><a href="Rivastigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rivastigmine" title="Rivastigmine">Rivastigmine</a></li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other medications</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bifemelane</li>
<li>Ginkgo folium</li>
<li>Meclofenoxate (centrophenoxine)</li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Nicergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicergoline" title="Nicergoline">Nicergoline</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Experimental BACE inhibitors</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Lanabecestat</li>
<li>Verubecestat</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Acetylcholine_metabolism_and_transport_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Acetylcholine_metabolism_and_transport_modulators" style="font-size:114%;margin:0 4em"><a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">Acetylcholine</a> metabolism and transport modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Enzyme<br><small>(modulators)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>ChAT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <span class="new">1-(-Benzoylethyl)pyridinium</span></li>
<li><span class="new">2-(α-Naphthoyl)ethyltrimethylammonium</span></li>
<li><span class="new">3-Chloro-4-stillbazole</span></li>
<li><span class="new">4-(1-Naphthylvinyl)pyridine</span></li>
<li><span class="new">Acetylseco hemicholinium-3</span></li>
<li><span class="new">Acryloylcholine</span></li>
<li><span class="new">AF64A</span></li>
<li><span class="new">B115</span></li>
<li><span class="new">BETA</span></li>
<li><span class="new">CM-54,903</span></li>
<li><span class="new">N,N-Dimethylaminoethylacrylate</span></li>
<li><span class="new">N,N-Dimethylaminoethylchloroacetate</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>AChE</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> <i>Reversible:</i> Carbamates: <a href="Aldicarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldicarb" title="Aldicarb">Aldicarb</a></li>
<li>Aminocarb</li>
<li><a href="Bendiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Bendiocarb" title="Bendiocarb">Bendiocarb</a></li>
<li><span class="new">Bufencarb</span></li>
<li><a href="Carbaryl.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbaryl" title="Carbaryl">Carbaryl</a></li>
<li><a href="Carbendazim.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbendazim" title="Carbendazim">Carbendazim</a></li>
<li><span class="new">Carbetamide</span></li>
<li><a href="Carbofuran.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbofuran" title="Carbofuran">Carbofuran</a></li>
<li>Carbosulfan</li>
<li><span class="new">Chlorbufam</span></li>
<li><span class="new">Chloropropham</span></li>
<li><a href="Dimetilan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimetilan" title="Dimetilan">Dimetilan</a></li>
<li>Ethienocarb</li>
<li>Ethiofencarb</li>
<li>Fenobucarb</li>
<li><a href="Formetanate.htm" tppabs="https://ptable.com/wiki/compounds/A/Formetanate" title="Formetanate">Formetanate</a></li>
<li>Formparanate</li>
<li><a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">Methiocarb</a></li>
<li><a href="Methomyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Methomyl" title="Methomyl">Methomyl</a></li>
<li><a href="Metolcarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Metolcarb" title="Metolcarb">Metolcarb</a></li>
<li>Miotine</li>
<li><a href="Oxamyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxamyl" title="Oxamyl">Oxamyl</a></li>
<li><span class="new">Phenmedipham</span></li>
<li><span class="new">Pinmicarb</span></li>
<li><a href="Pirimicarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirimicarb" title="Pirimicarb">Pirimicarb</a></li>
<li>Propamocarb</li>
<li><span class="new">Propham</span></li>
<li><a href="Propoxur.htm" tppabs="https://ptable.com/wiki/compounds/A/Propoxur" title="Propoxur">Propoxur</a></li>
<li>Thiofanox; Stigmines: Distigmine</li>
<li><span class="new">Eptastigmine</span></li>
<li><span class="new">Ganstigmine</span></li>
<li><a href="Neostigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Neostigmine" title="Neostigmine">Neostigmine</a></li>
<li><span class="new">Phenserine</span></li>
<li><a href="Physostigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Physostigmine" title="Physostigmine">Physostigmine</a></li>
<li><a href="Pyridostigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyridostigmine" title="Pyridostigmine">Pyridostigmine</a></li>
<li><span class="new">Quilostigmine</span></li>
<li><a href="Rivastigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rivastigmine" title="Rivastigmine">Rivastigmine</a></li>
<li><span class="new">Terestigmine</span>; Others: Acotiamide</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Ambenonium_chloride  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Ambenonium_chloride'" tppabs="https://ptable.com/wiki/compounds/A/Ambenonium" title="Ambenonium" class="mw-redirect">Ambenonium</a></li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a></li>
<li><a href="Donepezil.htm" tppabs="https://ptable.com/wiki/compounds/A/Donepezil" title="Donepezil">Donepezil</a></li>
<li>EA-3990</li>
<li>EA-4056</li>
<li><a href="Edrophonium.htm" tppabs="https://ptable.com/wiki/compounds/A/Edrophonium" title="Edrophonium">Edrophonium</a></li>
<li><a href="Galantamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Galantamine" title="Galantamine">Galantamine</a></li>
<li>Huperzine A</li>
<li>Ipidacrine</li>
<li>Itopride</li>
<li>Ladostigil</li>
<li><a href="Minaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Minaprine" title="Minaprine">Minaprine</a></li>
<li>Octamethylene-bis(5-dimethylcarbamoxyisoquinolinium bromide)</li>
<li>T-1123</li>
<li>TL-599</li>
<li>TL-1238</li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li>
<li><span class="new">Zanapezil</span></li></ul>

<ul><li><i>Irreversible:</i> Organophosphates: 2-Ethoxycarbonyl-1-methylvinyl cyclohexyl methylphosphonate</li>
<li><a href="Acephate.htm" tppabs="https://ptable.com/wiki/compounds/A/Acephate" title="Acephate">Acephate</a></li>
<li>Guanitoxin</li>
<li>Armine</li>
<li><a href="Azinphos-ethyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Azinphos-ethyl" title="Azinphos-ethyl">Azinphos-ethyl</a></li>
<li><a href="Azinphos-methyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Azinphos-methyl" title="Azinphos-methyl">Azinphos-methyl</a></li>
<li>BAY-29952</li>
<li><a href="Bensulide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bensulide" title="Bensulide">Bensulide</a></li>
<li><span class="new">Cadusafos</span></li>
<li><a href="Carbophenothion.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbophenothion" title="Carbophenothion">Carbophenothion</a></li>
<li>Chlorethoxyfos</li>
<li><a href="Chlorfenvinphos.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorfenvinphos" title="Chlorfenvinphos">Chlorfenvinphos</a></li>
<li><a href="Chlorpyrifos.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpyrifos" title="Chlorpyrifos">Chlorpyrifos</a></li>
<li><span class="new">Chlorpyrifos-methyl</span></li>
<li><a href="Coumaphos.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumaphos" title="Coumaphos">Coumaphos</a></li>
<li>Crotylsarin</li>
<li><a href="Cyanophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyanophos" title="Cyanophos">Cyanophos</a></li>
<li><a href="Cyclosarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclosarin" title="Cyclosarin">Cyclosarin (GF)</a></li>
<li>Demephion</li>
<li><a href="Demeton.htm" tppabs="https://ptable.com/wiki/compounds/A/Demeton" title="Demeton">Demeton</a></li>
<li><a href="Demeton-S-methyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Demeton-S-methyl" title="Demeton-S-methyl">Demeton-S-methyl</a></li>
<li><a href="Dialifor.htm" tppabs="https://ptable.com/wiki/compounds/A/Dialifor" title="Dialifor">Dialifor</a></li>
<li><a href="Diazinon.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazinon" title="Diazinon">Diazinon</a></li>
<li><a href="Dichlorvos.htm" tppabs="https://ptable.com/wiki/compounds/A/Dichlorvos" title="Dichlorvos">Dichlorvos</a></li>
<li><a href="Dicrotophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicrotophos" title="Dicrotophos">Dicrotophos</a></li>
<li><a href="Diisopropyl_fluorophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diisopropyl_fluorophosphate" title="Diisopropyl fluorophosphate">Diisopropyl fluorophosphate</a></li>
<li><a href="Diisopropylphosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Diisopropylphosphate" title="Diisopropylphosphate">Diisopropylphosphate</a></li>
<li><a href="Dimefox.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimefox" title="Dimefox">Dimefox</a></li>
<li><a href="Dimethoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoate" title="Dimethoate">Dimethoate</a></li>
<li><a href="Dimethyl_4-(methylthio)phenyl_phosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethyl_4-(methylthio)phenyl_phosphate" title="Dimethyl 4-(methylthio)phenyl phosphate">Dimethyl 4-(methylthio)phenyl phosphate</a></li>
<li><a href="Dioxathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Dioxathion" title="Dioxathion">Dioxathion</a></li>
<li><a href="Disulfoton.htm" tppabs="https://ptable.com/wiki/compounds/A/Disulfoton" title="Disulfoton">Disulfoton</a></li>
<li>EA-2012</li>
<li>EA-2054</li>
<li>EA-2098</li>
<li>EA-2192</li>
<li>EA-2613</li>
<li>EA-3148</li>
<li>EA-4352</li>
<li><a href="Echothiophate.htm" tppabs="https://ptable.com/wiki/compounds/A/Echothiophate" title="Echothiophate">Echothiophate</a></li>
<li>Ethylsarin (GE)</li>
<li><a href="Endothion.htm" tppabs="https://ptable.com/wiki/compounds/A/Endothion" title="Endothion">Endothion</a></li>
<li><a href="Ethion.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethion" title="Ethion">Ethion</a></li>
<li><a href="Ethoprop.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethoprop" title="Ethoprop" class="mw-redirect">Ethoprop</a></li>
<li><a href="Fenamiphos.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenamiphos" title="Fenamiphos">Fenamiphos</a></li>
<li><a href="Fenitrothion.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenitrothion" title="Fenitrothion">Fenitrothion</a></li>
<li><a href="Fenthion.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenthion" title="Fenthion">Fenthion</a></li>
<li>Fluorotabun</li>
<li><a href="Fonofos.htm" tppabs="https://ptable.com/wiki/compounds/A/Fonofos" title="Fonofos">Fonofos</a></li>
<li><a href="Formothion.htm" tppabs="https://ptable.com/wiki/compounds/A/Formothion" title="Formothion">Formothion</a></li>
<li><span class="new">Fosthiazate</span></li>
<li>GD-42</li>
<li>GH</li>
<li><span class="new">GT-45</span></li>
<li>GV</li>
<li>Hexaethyl tetraphosphate</li>
<li><a href="Diisopropyl_fluorophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Isofluorophate" title="Isofluorophate" class="mw-redirect">Isofluorophate</a></li>
<li><a href="Isoxathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoxathion" title="Isoxathion">Isoxathion</a></li>
<li><a href="Leptophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Leptophos" title="Leptophos">Leptophos</a></li>
<li><a href="Malaoxon.htm" tppabs="https://ptable.com/wiki/compounds/A/Malaoxon" title="Malaoxon">Malaoxon</a></li>
<li><a href="Malathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Malathion" title="Malathion">Malathion</a></li>
<li><a href="Methamidophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamidophos" title="Methamidophos">Methamidophos</a></li>
<li><a href="Methidathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Methidathion" title="Methidathion">Methidathion</a></li>
<li><a href="Methyl_phenkapton.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyl_phenkapton" title="Methyl phenkapton">Methyl phenkapton</a></li>
<li>Methylfluorophosphonylcholine (MFPCh)</li>
<li><a href="Metrifonate.htm" tppabs="https://ptable.com/wiki/compounds/A/Metrifonate" title="Metrifonate">Metrifonate</a></li>
<li><a href="Mevinphos.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevinphos" title="Mevinphos">Mevinphos</a></li>
<li>Mipafox</li>
<li><a href="Monocrotophos.htm" tppabs="https://ptable.com/wiki/compounds/A/Monocrotophos" title="Monocrotophos">Monocrotophos</a></li>
<li><a href="Naled.htm" tppabs="https://ptable.com/wiki/compounds/A/Naled" title="Naled">Naled</a></li>
<li>Novichok agent</li>
<li><a href="Omethoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Omethoate" title="Omethoate">Omethoate</a></li>
<li>Oxydemeton-methyl</li>
<li><a href="Paraoxon.htm" tppabs="https://ptable.com/wiki/compounds/A/Paraoxon" title="Paraoxon">Paraoxon</a></li>
<li><a href="Parathion.htm" tppabs="https://ptable.com/wiki/compounds/A/Parathion" title="Parathion">Parathion</a></li>
<li>Parathion-methyl</li>
<li><a href="Phorate.htm" tppabs="https://ptable.com/wiki/compounds/A/Phorate" title="Phorate">Phorate</a></li>
<li><a href="Phosalone.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosalone" title="Phosalone">Phosalone</a></li>
<li><a href="Phosfolan.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosfolan" title="Phosfolan">Phosfolan</a></li>
<li><a href="Phosmet.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosmet" title="Phosmet">Phosmet</a></li>
<li><a href="Phosphamidon.htm" tppabs="https://ptable.com/wiki/compounds/A/Phosphamidon" title="Phosphamidon">Phosphamidon</a></li>
<li><a href="Phoxim.htm" tppabs="https://ptable.com/wiki/compounds/A/Phoxim" title="Phoxim">Phoxim</a></li>
<li>Pirimiphos-methyl</li>
<li>Profenofos</li>
<li>Prothoate</li>
<li><span class="new">Ro 3-0340</span></li>
<li><span class="new">Ro 3-0346</span></li>
<li><span class="new">Ro 3-0347</span></li>
<li><span class="new">Ro 3-0351</span></li>
<li><span class="new">Ro 3-0352</span></li>
<li><span class="new">Ro 3-0397</span></li>
<li><span class="new">Ro 3-0411</span></li>
<li>Ro 3-0412</li>
<li><span class="new">Ro 3-0417</span></li>
<li>Ro 3-0419</li>
<li>Ro 3-0422</li>
<li><span class="new">Ro 3-0433</span></li>
<li><a href="Sarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sarin" title="Sarin">Sarin (GB)</a></li>
<li>Schradan</li>
<li><a href="Soman.htm" tppabs="https://ptable.com/wiki/compounds/A/Soman" title="Soman">Soman (GD)</a></li>
<li><a href="Tabun_(nerve_agent).htm" tppabs="https://ptable.com/wiki/compounds/A/Tabun_(nerve_agent)" title="Tabun (nerve agent)">Tabun (GA)</a></li>
<li>Tebupirimfos</li>
<li><a href="Temefos.htm" tppabs="https://ptable.com/wiki/compounds/A/Temefos" title="Temefos">Temefos</a></li>
<li>Terbufos</li>
<li>Tetrachlorvinphos</li>
<li><a href="Tetraethyl_pyrophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetraethyl_pyrophosphate" title="Tetraethyl pyrophosphate">Tetraethyl pyrophosphate</a></li>
<li>Triazofos</li>
<li><span class="new">Tribufos</span></li>
<li><a href="Metrifonate.htm" tppabs="https://ptable.com/wiki/compounds/A/Trichlorfon" title="Trichlorfon" class="mw-redirect">Trichlorfon</a></li>
<li>Trichloronate</li>
<li><a href="Tricresyl_phosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tricresyl_phosphate" title="Tricresyl phosphate">Tricresyl phosphate</a></li>
<li>VE</li>
<li><a href="VG_(nerve_agent).htm" tppabs="https://ptable.com/wiki/compounds/A/VG_(nerve_agent)" title="VG (nerve agent)">VG</a></li>
<li>VM</li>
<li>VP</li>
<li>VS</li>
<li>VR</li>
<li>VX; Others: Demecarium</li>
<li>Fasciculins (green mamba toxins) (<span class="new">1</span>, <span class="new">2</span>, <span class="new">3</span>, <span class="new">4</span>)</li>
<li>Onchidal (<i>Onchidella binneyi</i>)</li>
<li><a href="Methanesulfonyl_fluoride.htm" tppabs="https://ptable.com/wiki/compounds/A/Methanesulfonyl_fluoride" title="Methanesulfonyl fluoride">Methanesulfonyl fluoride</a></li></ul>

<ul><li><i>Unsorted:</i> α-Pinene</li>
<li>α-Viniferin</li>
<li>Affinine</li>
<li>Affinisine</li>
<li>Arisugacin A</li>
<li>Bulbocapnine</li>
<li>Conodurine</li>
<li>Coronaridine</li>
<li>Corydaline</li>
<li>Corynoline</li>
<li><a href="Crimidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Crimidine" title="Crimidine">Crimidine</a></li>
<li>Cyclanoline</li>
<li>Cymserine</li>
<li><a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">Harmaline</a></li>
<li>Kobophenol A</li>
<li>Lactucopicrin</li>
<li>Lycorine</li>
<li>Phosacetim</li>
<li><a href="Rosmarinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosmarinic_acid" title="Rosmarinic acid">Rosmarinic acid</a></li>
<li>Stercuronium iodide</li>
<li>Taspine</li>
<li><a href="Tetrahydrocannabinol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydrocannabinol" title="Tetrahydrocannabinol">Tetrahydrocannabinol</a></li>
<li>Ungeremine</li>
<li>Ungiminorine</li>
<li>Dimethylcarbamoyl fluoride</li>
<li>BW284C51</li>
<li>TMTFA</li></ul>

<ul><li><b>Reactivators:</b> Asoxime chloride</li>
<li><span class="new">Methoxime</span></li>
<li><a href="Obidoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Obidoxime" title="Obidoxime">Obidoxime</a></li>
<li><a href="Pralidoxime.htm" tppabs="https://ptable.com/wiki/compounds/A/Pralidoxime" title="Pralidoxime">Pralidoxime</a></li>
<li>Trimedoxime bromide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>BChE</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> Affinine</li>
<li>Affinisine</li>
<li>Conodurine</li>
<li>Cymserine</li>
<li>Ladostigil</li>
<li><a href="Profenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Profenamine" title="Profenamine">Profenamine (ethopropazine)</a></li>
<li><a href="Rivastigmine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rivastigmine" title="Rivastigmine">Rivastigmine</a></li>
<li><a href="Tacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrine" title="Tacrine">Tacrine</a></li>
<li><span class="new">ZINC-12613047</span></li>
<li>Many of the other AChE inhibitors listed above</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Transporter<br><small>(modulators)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>CHT</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> Hemicholinium-3 (hemicholine)</li>
<li>Triethylcholine</li></ul>

<ul><li><b>Enhancers:</b> Coluracetam</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;"><abbr>VAChT</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>Inhibitors:</b> Vesamicol</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Release<br><small>(modulators)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><abbr>SNAP-25</abbr> inactivators:</b> <a href="Botulinum_toxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Botulinum_toxin" title="Botulinum toxin">Botulinum toxin</a> (A, <span class="new">C</span>, <span class="new">E</span>)</li></ul>

<ul><li><b><abbr>VAMP</abbr> inactivators:</b> <a href="Botulinum_toxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Botulinum_toxin" title="Botulinum toxin">Botulinum toxin</a> (<span class="new">B</span>, <span class="new">D</span>, <span class="new">F</span>, <span class="new">G</span>)</li></ul>

<ul><li><b>Others:</b> Bungarotoxins (β-bungarotoxin, γ-bungarotoxin)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Enhancers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><abbr>LPHN</abbr> agonists:</b> α-Latrotoxin</li></ul>

<ul><li><b>Others:</b> Atracotoxins (e.g., robustoxin, <span class="new">versutoxin</span>)</li>
<li>Crotoxin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Muscarinic acetylcholine receptor modulators • Nicotinic acetylcholine receptor modulators</i></div></td></tr></tbody></table></div><span>
</span>





<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-06-23" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Rivastigmine&oldid=964134688  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Rivastigmine&oldid=964134688'" tppabs="https://en.wikipedia.org/wiki/?title=Rivastigmine&oldid=964134688">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>